Related Experiment Video
Updated: May 10, 2026

Protocol for Production of a Genetic Cross of the Rodent Malaria Parasites
Published on: January 3, 2011
[Malaria and children who travel - prophylaxis and therapy]
Patricia Schlagenhauf1, Sabine Haller, Noémie Wagner
1Zentrum für Reisemedizin, Institut für Sozial- und Präventivmedizin, World Health Organization, Collaborating Centre for Travellers' Health, Universität Zürich. pat@ifspm.uzh.ch
Insights
Preventing imported malaria in traveling children involves awareness, bite prevention, and appropriate chemoprophylaxis. Early diagnosis and treatment are crucial for pediatric malaria, an emergency requiring prompt medical attention.
Area of Science:
- Pediatric Infectious Diseases
- Travel Medicine
- Global Health
Context:
- Children represent 15-20% of imported malaria cases globally, with highest risk among immigrant children visiting sub-Saharan Africa.
- Malaria prevention in pediatric travelers relies on the ABCD principles: Awareness, Bite prevention, Chemoprophylaxis, and Diagnosis/Treatment.
- Limited pediatric data on antimalarial dosage, pharmacokinetics, and tolerability complicates prevention strategies.
Purpose:
- To provide guidance on malaria prevention and management in children traveling to endemic areas.
- To highlight practical advice for pre-travel consultations, including mosquito bite prevention and specific antimalarial dosages.
- To emphasize the importance of prompt diagnosis and treatment for pediatric malaria.
Summary:
- Pre-travel advice should cover mosquito protection and precise weight-based antimalarial dosages for chemoprophylaxis or standby treatment.
- Paediatric formulations of atovaquone-proguanil (for >11 kg) and mefloquine (for >5 kg) are available for prophylaxis.
- Artemether-lumefantrine dispersible tablets are recommended for standby emergency treatment in young children; post-travel illness requires immediate malaria suspicion and care.
Impact:
- Ensuring appropriate malaria prevention strategies for pediatric travelers can reduce the burden of imported malaria in non-endemic regions.
- Improved adherence to chemoprophylaxis through practical advice and palatable formulations can enhance protection.
- Timely diagnosis and treatment of pediatric malaria are critical to prevent severe outcomes and mortality.
Abstract:
Children account for between 15 - 20 % of all imported malaria cases worldwide. Immigrant children visiting their families in the country of origin in sub-Saharan Africa are at highest risk. Prevention of malaria in children who travel to endemic areas is guided by the ABCD principles - Awareness of risk, Bite prevention, Chemoprophylaxis for high risk areas and rapid Diagnosis and treatment when malaria is suspected. The use of anti-malarial medication in small children is hampered by a paucity of dosage, pharmcokinetic and tolerability data. In the pre-travel consultation parents should be provided with practical advice on anti-mosquito measures, exact, (weight-based) dosages of chemoprophylaxis medication and/or stand-by treatment as indicated. A paediatric formulation is available for daily atovaquone-proguanil chemoprophylaxis (children > 11 kg) and mefloquine is a cost-effective, once weekly prophylaxis that is useful for children > 5 kg who travel for longer periods. The bitter taste of mefloquine should be disguised to increase adherence. When a Stand-by Emergency Treatment (SBET) is indicated, artemether-lumefantrine cherry flavoured dispersible tablets are a good choice for small children. Post-travel to endemic areas, malaria should always be suspected if a child becomes ill. Paediatric malaria is an emergency requiring prompt diagnosis and appropriate treatment.
More Related Videos
05:28Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
Published on: May 12, 2022
09:13Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases
Published on: November 22, 2024
Related Concept Videos
Symbiosis
Anthelminthic Agents
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Fungal Phylum Microsporidia
Pharmacokinetics in Pediatric Patients: Drug Metabolism